Inflammatory Bowel disease (IBD) affects over 200,000 Canadians. Individuals with IBD have significantly greater risk of developing colorectal cancer. Unfortunately, the screening for colorectal cancer that is currently provided to the general population is inadequate for this group. White light colonoscopy is currently the gold standard but is challenging, as lesions are sometimes difficult to […]
Read More